These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29089645)

  • 21. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
    Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte.
    Nukaya I; Yasumoto M; Iwasaki T; Ideno M; Sette A; Celis E; Takesako K; Kato I
    Int J Cancer; 1999 Jan; 80(1):92-7. PubMed ID: 9935237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.
    de Alwis R; Bangs DJ; Angelo MA; Cerpas C; Fernando A; Sidney J; Peters B; Gresh L; Balmaseda A; de Silva AD; Harris E; Sette A; Weiskopf D
    J Virol; 2016 May; 90(9):4771-4779. PubMed ID: 26912627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.
    Minami T; Minami T; Shimizu N; Yamamoto Y; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H
    Int Immunopharmacol; 2014 May; 20(1):59-65. PubMed ID: 24583149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
    Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
    Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
    Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen.
    Li Y; Zhou W; Du J; Jiang C; Xie X; Xue T; He Y
    Cancer Immunol Immunother; 2015 Feb; 64(2):259-69. PubMed ID: 25376540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 molecules.
    Kondo S; Demachi-Okamura A; Hirosawa T; Maki H; Fujita M; Uemura Y; Akatsuka Y; Yamamoto E; Shibata K; Ino K; Kikkawa F; Kuzushima K
    Hum Immunol; 2013 Sep; 74(9):1103-10. PubMed ID: 23806269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
    Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
    J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
    Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
    Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
    Oiso M; Eura M; Katsura F; Takiguchi M; Sobao Y; Masuyama K; Nakashima M; Itoh K; Ishikawa T
    Int J Cancer; 1999 May; 81(3):387-94. PubMed ID: 10209953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
    Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
    Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.
    Arai J; Yasukawa M; Ohminami H; Kakimoto M; Hasegawa A; Fujita S
    Blood; 2001 May; 97(9):2903-7. PubMed ID: 11313288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patients.
    Kobayashi K; Noguchi M; Itoh K; Harada M
    Cancer Sci; 2003 Jul; 94(7):622-7. PubMed ID: 12841872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.
    Gomi S; Nakao M; Niiya F; Imamura Y; Kawano K; Nishizaka S; Hayashi A; Sobao Y; Oizumi K; Itoh K
    J Immunol; 1999 Nov; 163(9):4994-5004. PubMed ID: 10528204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma.
    Jalili A; Ozaki S; Hara T; Shibata H; Hashimoto T; Abe M; Nishioka Y; Matsumoto T
    Blood; 2005 Nov; 106(10):3538-45. PubMed ID: 16037388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
    Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R
    Immunology; 2010 Mar; 129(3):386-95. PubMed ID: 19922423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
    Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
    Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24 allele.
    Wang Y; Sun M; He M; Cui H; Zhang J; Shi L; Wang W; Xu W; Gao B; Ding J
    Microb Pathog; 2012 Sep; 53(3-4):162-7. PubMed ID: 22819798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.